×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| GUFIC BIOSCIENCES LTD. | 2278.06 | 120.73 | 2269.11 | 1.2 | 3,589 | 58.0 |
| UNICHEM LABORATORIES LTD. | 3885.0 | -18.5 | 3842.5 | -0.26 | 3523 | 28.2 |
| IOL CHEMICALS & PHARMACEUTICAL | 5590.6 | 339.6 | 5516.9 | 1.16 | 3417 | 32.6 |
Gufic BioSciences Ltd., with Security Code 509079, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 173.0 | 195.0 | 214.9 | 201.8 | 195.0 | 202.8 | 204.2 | 207.8 | 205.0 | 226.9 |
| Expenses | 140.9 | 159.5 | 175.5 | 165.3 | 160.8 | 167.0 | 165.6 | 173.9 | 178.4 | 194.6 |
| Operating Profit | 32.1 | 35.5 | 39.4 | 36.5 | 34.2 | 35.8 | 38.6 | 33.9 | 26.7 | 32.3 |
| OPM % | 18.58% | 18.19% | 18.32% | 18.07% | 17.55% | 17.64% | 18.92% | 16.33% | 13.01% | 14.25% |
| Other Income | 0.6 | 0.9 | 0.3 | 0.4 | 0.9 | 1.3 | 0.1 | 1.9 | 0.4 | 0.9 |
| Interest | 2.9 | 4.1 | 4.5 | 3.2 | 3.6 | 4.6 | 5.2 | 4.9 | 8.4 | 9.2 |
| Depreciation | 5.9 | 4.2 | 4.3 | 4.1 | 4.3 | 4.3 | 4.3 | 4.6 | 7.8 | 7.7 |
| Profit before tax | 23.9 | 28.0 | 30.9 | 29.6 | 27.1 | 28.1 | 29.3 | 26.3 | 10.8 | 16.3 |
| Tax % | -24.3% | -26.5% | -25% | -24.7% | -26.1% | -25.8% | -25.6% | 26.5% | -26% | 25.8% |
| Net Profit | 18.1 | 20.6 | 23.2 | 22.3 | 20.0 | 20.9 | 21.8 | 19.3 | 8.0 | 12.1 |
| EPS in Rs | 1.87 | 2.13 | 2.39 | 2.23 | 2 | 2.08 | 2.17 | 1.93 | 0 | 1.2 |
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Sales | 214.9 | 201.8 | 195.0 | 202.8 | 204.2 | 207.8 | 205.0 |
| Expenses | 175.5 | 165.3 | 160.8 | 167.0 | 165.6 | 173.9 | 178.6 |
| Operating Profit | 39.4 | 36.5 | 34.2 | 35.8 | 38.6 | 33.9 | 26.5 |
| OPM % | 18.32% | 18.07% | 17.55% | 17.64% | 18.91% | 16.33% | 12.91% |
| Other Income | 0.3 | 0.4 | 0.9 | 1.3 | 0.1 | 1.9 | 0.4 |
| Interest | 4.5 | 3.2 | 3.6 | 4.6 | 5.2 | 4.9 | 8.4 |
| Depreciation | 4.3 | 4.1 | 4.3 | 4.3 | 4.3 | 4.6 | 7.8 |
| Profit before tax | 30.9 | 29.6 | 27.1 | 28.1 | 29.3 | 26.3 | 10.6 |
| Tax % | -25% | -24.7% | -26.1% | 25.8% | 25.6% | -26.5% | -26.6% |
| Net Profit | 23.2 | 22.3 | 20.0 | 20.9 | 21.8 | 19.3 | 7.7 |
| EPS in Rs | 2.39 | 2.23 | 2 | 2.08 | 2.17 | 1.93 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 32% |
| 3 Years: | 26% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 47% |
| 3 Years: | 19% |
| 1 Year: | 10% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 47% |
| 3 Years: | 19% |
| 1 Year: | 10% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|